company background image
8329 logo

Shenzhen Neptunus Interlong Bio-technique SEHK:8329 Stock Report

Last Price

HK$0.16

Market Cap

HK$265.1m

7D

14.5%

1Y

-3.1%

Updated

08 Oct, 2024

Data

Company Financials

Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$265.1m

8329 Stock Overview

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

8329 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Shenzhen Neptunus Interlong Bio-technique Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenzhen Neptunus Interlong Bio-technique
Historical stock prices
Current Share PriceHK$0.16
52 Week HighHK$0.18
52 Week LowHK$0.12
Beta0.20
11 Month Change23.44%
3 Month Change18.80%
1 Year Change-3.07%
33 Year Change-34.17%
5 Year Change-39.23%
Change since IPO-56.71%

Recent News & Updates

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Recent updates

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Apr 19
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Shareholder Returns

8329HK PharmaceuticalsHK Market
7D14.5%4.2%0.4%
1Y-3.1%29.7%18.4%

Return vs Industry: 8329 underperformed the Hong Kong Pharmaceuticals industry which returned 37.7% over the past year.

Return vs Market: 8329 underperformed the Hong Kong Market which returned 30.6% over the past year.

Price Volatility

Is 8329's price volatile compared to industry and market?
8329 volatility
8329 Average Weekly Movement9.9%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement8.7%
10% most volatile stocks in HK Market18.2%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 8329 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 8329's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,471n/awww.interlong.com

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. It offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. The company is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business.

Shenzhen Neptunus Interlong Bio-technique Company Limited Fundamentals Summary

How do Shenzhen Neptunus Interlong Bio-technique's earnings and revenue compare to its market cap?
8329 fundamental statistics
Market capHK$265.12m
Earnings (TTM)HK$35.44m
Revenue (TTM)HK$1.16b

7.5x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8329 income statement (TTM)
RevenueCN¥1.05b
Cost of RevenueCN¥658.52m
Gross ProfitCN¥395.31m
Other ExpensesCN¥363.16m
EarningsCN¥32.15m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.019
Gross Margin37.51%
Net Profit Margin3.05%
Debt/Equity Ratio8.5%

How did 8329 perform over the long term?

See historical performance and comparison